In the news

Targeting cancer-related mechanisms is just the tip of the iceberg for personalized medicine

Read article from our CEO, Duleek Ranatunga, following this link here.

See what we have in the works

Our drug discovery pipeline is focused on a range of indications from breast to lung cancer. Explore more about our pipeline.